pasireotide [6124]



pasireotide


SMILES NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O
InChIKey VMZMNAABQBOLAK-DBILLSOUSA-N
Sequence XXWKYF

Chemical Properties

Hydrogen bond acceptors 11
Hydrogen bond donors 9
Rotatable bonds 17
Log P 3.368
Molecular weight (Da) 1046.5
Stereochemistry info partial


No bioactivity data available.

pasireotide


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.